On April 4, 2011, the USPTO issued a Notice in the Federal Register announcing the implementation of fee-based prioritized examination, also known as “Track I” of its three tracks of examination options proposed in June of 2010. Track I will be available for non-reissue applications filed on or after May 4, 2011. While this program may be attractive to applicants seeking prompt examination, some of the details warrant a closer look.
Tag Archives: Rulemaking
USPTO Proposes To Simplify Patent Appeal Practice
Posted by Courtenay Brinckerhoff on Posted in USPTO Proposed Rule ChangesThe USPTO has published proposed changes to the rules governing practice before the Board of Patent Appeals and Interferences. While the proposed changes salvage a few elements from the 2008 "Final Rules" that never took effect, the USPTO plans to rescind that rules package. In its place, the USPTO has proposed a rules package that appears to strike a reasonable balance between facilitating Board review and simplifying the appeals process for applicants.
Subscribe to This Blog
Topics
- 101
- 102
- 103
- Bilski
- Biosimilars
- Claim Construction
- District Court Decisions
- Doctrine of Equivalents
- Duty of Disclosure
- Enablement
- Federal Circuit Decisions
- Inequitable Conduct
- Infringement
- International Patent Practice
- Life Sciences Agreements
- Myriad
- Obviousness Type Double Patenting
- Patent Office Practice
- Patent Reform
- Patent Term Adjustment
- Patent Term Extension
- Patent Trials
- Personalized Medicine
- Prometheus
- Reasonable Royalty
- Reexam
- Supreme Court Decisions
- Uncategorized
- USPTO Board Decisions
- USPTO Proposed Rule Changes
- Written Description
Recent Updates
- A Look At The Myriad Gene Patent Claims And The USPTO Memo To Examiners On Myriad
- Supreme Court Decides Myriad Gene Patents Case, Holds Isolated Human Genes May Not Be Patented
- Monsanto Avoids Declaratory Judgment Action Brought By Organic Farmers
- White House Announces Initiatives Against Patent Trolls
- Congressman Goodlatte Proposes To Codify Obviousness-Type Double Patenting
